Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Blood Advances|July 28, 2025
Targeting S100A9-mediated inflammation: A novel therapeutic approach for CLLAngimar Uriepero-Palma, Maria Elena Marquez, Eugenia Payque, et al.
The Journal of Clinical Investigation|December 3, 2020
Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in miceCarly M Harro, Jairo Perez-Sanz, Tara Lee Costich, et al.
Blood Advances|April 23, 2021
Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromesGrace A Ward, Kathy L McGraw, Farnoosh Abbas-Aghababazadeh, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Hematopoietic mosaic chromosomal alterations are pleiotropic drivers of inflammaging, multimorbidity, and mortalityNicole D Vincelette, Qianxing Mo, Chia-Ho Cheng, et al.
The Lancet. Haematology|August 4, 2018
Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort studyAshley A Basiorka, Kathy L McGraw, Farnoosh Abbas-Aghababazadeh, et al.
Haematologica|February 2, 2023
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysisJerald P Radich, Matthew Wall, Susan Branford, et al.
Blood Advances|August 2, 2023
Sézary syndrome originates from heavily mutated hematopoietic progenitorsCarly M Harro, Kimberly B Sprenger, Ricardo A Chaurio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2021
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III TrialJohn C Byrd, Peter Hillmen, Paolo Ghia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Chronic Myelogenous Leukemia, Version 1.2014Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.
Transplantation and Cellular Therapy|June 13, 2025
Clinical practice recommendations on the role of allogeneic hematopoietic cell transplantation and chimeric antigen receptor T-cell therapy in patients with chronic lymphocytic leukemia on behalf of the American Society for Transplantation and Cellular TherapyMohamed A Kharfan-Dabaja, Ambuj Kumar, Javier Pinilla-Ibarz, et al.
Pageof 16